drugset
drugset / Trial / NCT00026286

Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer

NCT00026286 ↗

Phase 3 Completed Eastern Cooperative Oncology Group National Cancer Institute (NCI) · collab
RandomizedDouble-blindSupportive care

Summary

RATIONALE: Hormone replacement therapy may be effective in managing the hot flashes and/or vaginal symptoms in postmenopausal women who are receiving tamoxifen for breast cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of hormone replacement therapy in managing hot flashes and/or vaginal symptoms in postmenopausal women who are receiving tamoxifen for breast cancer.

Timeline

Start
2000-11-28
Primary completion
2002-08
Completion
2007-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject conjugated estrogens Other / unclassified — Oral
Subject medroxyprogesterone acetate Other / unclassified — Oral

Indications

breast cancer